Literature DB >> 31696389

Predictors and prognostic impact of secondary mitral regurgitation in myocardial infarction with preserved ejection fraction.

Maki Nogi1, Hiroyuki Okura2, Toru Kataoka3, Kiyoshi Yoshida4.   

Abstract

BACKGROUND: Secondary or functional mitral regurgitation (FMR) has been reported associated with poor prognosis in patients with ischemic or non-ischemic cardiomyopathy. Prognostic impact of the FMR in myocardial infarction with preserved ejection fraction (MIpEF) is unknown. The aim of this study was to investigate predictors and prognostic impact of FMR in MIpEF.
METHODS: A total of 556 patients with MIpEF were selected from the Bell Land General Hospital MI (BELAMI) registry (n = 953). Patients were grouped according to the presence or absence of severe FMR. Clinical endpoint was all-cause death.
RESULTS: Severe FMR was present in 26 patients (4.7%) (FMR group) and absent in 530 patients (control). FMR group was older (77.5 ± 7.2 vs. 67.3 ± 11.3 years, P < 0.01) and had more female gender (54% vs. 28%, P < 0.01). By echocardiography, FMR group had larger left atrial diameter and left ventricular end-systolic volume. E and E/e' were significantly higher and deceleration time of E was significantly shorter in FMR group. By Kaplan-Meier analysis, survival was significantly lower in FMR group than in control (log-rank, P = 0.004).
CONCLUSION: Severe FMR is rare in MI patients with preserved EF but is associated with poor long-term prognosis.

Entities:  

Keywords:  Mitral regurgitation; Myocardial infarction; Prognosis; Systolic function

Mesh:

Year:  2019        PMID: 31696389     DOI: 10.1007/s12574-019-00451-y

Source DB:  PubMed          Journal:  J Echocardiogr        ISSN: 1349-0222


  25 in total

Review 1.  Secondary mitral regurgitation in heart failure with reduced or preserved left ventricular ejection fraction.

Authors:  Pierre Vladimir Ennezat; Sylvestre Maréchaux; Philippe Pibarot; Thierry H Le Jemtel
Journal:  Cardiology       Date:  2013-05-24       Impact factor: 1.869

2.  Quantification of mitral valve apparatus by three-dimensional transesophageal echocardiography: in vitro validation study comparing two different analysis systems.

Authors:  Ken Saito; Hiroyuki Okura; Nozomi Watanabe; Koichiro Imai; Tomoko Tamada; Terumasa Koyama; Akihiro Hayashida; Yoji Neishi; Takahiro Kawamoto; Kiyoshi Yoshida
Journal:  J Echocardiogr       Date:  2011-05-21

3.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2017-09-21       Impact factor: 29.983

4.  The perindopril in elderly people with chronic heart failure (PEP-CHF) study.

Authors:  John G F Cleland; Michal Tendera; Jerzy Adamus; Nick Freemantle; Lech Polonski; Jacqueline Taylor
Journal:  Eur Heart J       Date:  2006-09-08       Impact factor: 29.983

5.  Quantitation of mitral valve tenting in ischemic mitral regurgitation by transthoracic real-time three-dimensional echocardiography.

Authors:  Nozomi Watanabe; Yasuo Ogasawara; Yasuko Yamaura; Takahiro Kawamoto; Eiji Toyota; Takashi Akasaka; Kiyoshi Yoshida
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

6.  Renin-angiotensin system inhibitors in patients with myocardial infarction and secondary mitral regurgitation.

Authors:  Hiroyuki Okura; Toru Kataoka; Kiyoshi Yoshida
Journal:  Heart       Date:  2016-02-10       Impact factor: 5.994

7.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

8.  Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation.

Authors:  Y Otsuji; M D Handschumacher; N Liel-Cohen; H Tanabe; L Jiang; E Schwammenthal; J L Guerrero; L A Nicholls; G J Vlahakes; R A Levine
Journal:  J Am Coll Cardiol       Date:  2001-02       Impact factor: 24.094

9.  Prevalence and Prognostic Significance of Functional Mitral and Tricuspid Regurgitation Despite Preserved Left Ventricular Ejection Fraction in Atrial Fibrillation Patients.

Authors:  Yukio Abe; Kanako Akamatsu; Kazato Ito; Yoshiki Matsumura; Kenji Shimeno; Takahiko Naruko; Yosuke Takahashi; Toshihiko Shibata; Minoru Yoshiyama
Journal:  Circ J       Date:  2018-03-16       Impact factor: 2.993

10.  Quantitative measurement of mitral valve coaptation in functional mitral regurgitation: In vivo experimental study by real-time three-dimensional echocardiography.

Authors:  Ryotaro Yamada; Nozomi Watanabe; Teruyoshi Kume; Miwako Tsukiji; Takahiro Kawamoto; Yoji Neishi; Akihiro Hayashida; Eiji Toyota; Hiroyuki Okura; Kiyoshi Yoshida
Journal:  J Cardiol       Date:  2008-11-08       Impact factor: 3.159

View more
  1 in total

1.  Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation.

Authors:  Kaeko Hirai; Rika Kawakami; Maki Nogi; Satomi Ishihara; Yukihiro Hashimoto; Yasuki Nakada; Hitoshi Nakagawa; Tomoya Ueda; Taku Nishida; Kenji Onoue; Tsunenari Soeda; Satoshi Okayama; Makoto Watanabe; Hiroyuki Okura; Yoshihiko Saito
Journal:  Circ Rep       Date:  2021-06-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.